瘤学研究和实践中的财务毒性查:叙述性审查
Jeffrey Peppercorn1, Matthew Gelin1, Taylor E Masteralexis1
1Department of Medicine, Massachusetts General Hospital, Boston, MA.
JCO oncology practice
|January 10, 2025
概括
金融毒性 (FT) 是癌症患者的重大负担,越来越多地通过验证的研究工具来解决. 目前正在努力开发临床实践的简短查方法,以帮助那些面临财务困境的人.
科学领域:
- 在瘤学瘤学.
- 卫生经济学 卫生经济学
- 患者支持 患者支持
背景情况:
- 金融毒性 (FT) 是一个影响癌症患者及其家属的公认问题.
- 该领域正在从问题描述转向开发查和管理解决方案.
- 对于FT研究存在多种验证的工具,临床查正在进行开发.
研究的目的:
- 审查在研究环境中研究FT的验证尺度.
- 为FT的临床查提供正在评估的工具示例.
- 突出识别和协助FT患者的重要性.
主要方法:
- 关于FT评估工具的现有文献的叙事综述.
- 在研究中使用的验证尺度的分析.
- 检查正在研究临床实施的工具.
主要成果:
- 许多验证的工具可用于FT研究.
- 新出现的证据支持对金融困境进行简短的查 (1-2个问题).
- 目前正在测试各种工具,以实现常规临床实践的整合.
结论:
- 临床医生应该积极识别和支持患有FT的患者.
- 经过验证的研究工具为临床查开发提供了基础.
- 有效的FT查和管理对于全面的癌症护理至关重要.
相关概念视频
Nursing Ethical Principles II
917
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
917
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
119
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
119
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K


